NIRMAN AGRI GENETICS
Back to Balance Sheet
|
NIRMAN AGRI GENETICS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹3.14 Cr | ₹6.88 Cr | ₹2.14 Cr | ₹2.07 Cr | ₹0.58 Cr |
What is the latest Total Current Liabilities ratio of NIRMAN AGRI GENETICS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹3.14 Cr |
| Mar2024 | ₹6.88 Cr |
| Mar2023 | ₹2.14 Cr |
| Mar2022 | ₹2.07 Cr |
| Mar2021 | ₹0.58 Cr |
How is Total Current Liabilities of NIRMAN AGRI GENETICS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.14 Cr | -54.45 | |
| Mar2024 | ₹6.88 Cr | 221.29 | |
| Mar2023 | ₹2.14 Cr | 3.58 | |
| Mar2022 | ₹2.07 Cr | 254.11 | |
| Mar2021 | ₹0.58 Cr | - | |
Compare Total Current Liabilities of peers of NIRMAN AGRI GENETICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NIRMAN AGRI GENETICS | ₹34.8 Cr | -5.2% | -18% | -76.6% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹9,894.0 Cr | -8.2% | -20.3% | -19.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,149.9 Cr | 5.5% | -0.5% | -33% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,777.5 Cr | -4.4% | -8.4% | -22.3% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹774.9 Cr | -9% | -20.4% | -40.5% | Stock Analytics | |
| INDO US BIOTECH | ₹205.2 Cr | -5.5% | -33.1% | -35% | Stock Analytics | |
NIRMAN AGRI GENETICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NIRMAN AGRI GENETICS | -5.2% |
-18% |
-76.6% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses